Menopausal HT for Women Living With HIV (HoT)
Sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
About this study
Women living with HIV have been shown to experience more frequent and severe hot flashes and night sweats (collectively known as vasomotor symptoms) as compared to women living without HIV. This correlates with disturbed sleep, increased depressive symptoms, increased anxiety, worse mental function, interference with activities of daily living including work, and worse overall quality of life. Hormone therapy is considered to be the most effective therapy for hot flashes and night sweats and the most appropriate choice to prevent bone loss at the time of menopause for women without HIV. However, the usefulness of hormone therapy has not been specifically studied in women living with HIV. This trial is being done to see if: * There is evidence to support the use of hormone therapy (estradiol with or without progesterone) for the treatment of hot flashes and night sweats in women living with HIV * Hormone therapy improves mental function, mood, sleep, quality of life, bone health, heart health, and inflammation in women living with HIV * Hormone therapy is safe and tolerable for women living with HIV
Where this study is enrolling (23)
- I'm interested
31788 Alabama CRS
Birmingham, Alabama
- I'm interested
Harbor - UCLA Med. Ctr. CRS
Torrance, California
- I'm interested
University of California, Los Angeles CARE Center CRS (601)
Los Angeles, California
- I'm interested
UCSD Antiviral Research Center CRS (701)
San Diego, California
- I'm interested
801 University of California, San Francisco HIV/AIDS CRS
San Francisco, California
Show all 23 locations
- I'm interested
University of Colorado Hospital CRS (6101)
Aurora, Colorado
- I'm interested
The Ponce de Leon Center CRS (5802)
Atlanta, Georgia
- I'm interested
Northwestern University CRS (2701)
Chicago, Illinois
- I'm interested
201 Johns Hopkins University CRS
Baltimore, Maryland
- I'm interested
Brigham and Women's Hosp. ACTG CRS (107)
Boston, Massachusetts
- I'm interested
101 Massachusetts General Hospital (MGH) CRS
Boston, Massachusetts
- I'm interested
2101 Washington University Therapeutics (WT) CRS
St Louis, Missouri
- I'm interested
New Jersey Medical School Clinical Research Center CRS (31786)
Newark, New Jersey
- I'm interested
Weill Cornell Chelsea CRS (7804)
New York, New York
- I'm interested
Columbia Physicians and Surgeons (P&S) CRS (30329)
New York, New York
- I'm interested
3203 Greensboro CRS
Greensboro, North Carolina
- I'm interested
3201 Chapel Hill CRS
Chapel Hill, North Carolina
- I'm interested
Case CRS (2501)
Cleveland, Ohio
- I'm interested
Ohio State University CRS (2301)
Columbus, Ohio
- I'm interested
2401 Cincinnati CRS
Cincinnati, Ohio
- I'm interested
Univ of Pittsburgh
Pittsburgh, Pennsylvania
- I'm interested
6201 Penn Therapeutics CRS
Philadelphia, Pennsylvania
- I'm interested
Houston AIDS Research Team CRS (31473)
Houston, Texas
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.